<DOC>
	<DOCNO>NCT01917929</DOCNO>
	<brief_summary>This study prospective , open-label , post-market , non-randomized , multi-center clinical evaluation Secur-Fit Advanced Hip Stem primary total hip arthroplasty cementless application consecutive series patient meet eligibility criterion . The success rate Secur-Fit Advanced femoral stem , define absence stem revision aseptic loosening femoral fracture , expect bad 99 % 5 year postoperative non-inferiority margin 2.5 % .</brief_summary>
	<brief_title>Secur-Fit Advanced Outcomes Study</brief_title>
	<detailed_description />
	<criteria>Patient sign Institutional Review Board ( IRB ) /Ethics Committee ( EC ) approve , study specific Informed Patient Consent Form . Patient male nonpregnant female , skeletally mature age 2175 year time study device implantation . Patient diagnosis NonInflammatory Degenerative Joint Disease . Patient candidate primary total hip arthroplasty . Patient willing able comply postoperative schedule clinical radiographic evaluation rehabilitation . Patient previously undergone open surgical intervention operative hip . Patient prior femoral fracture , without deformity , operative side . Patient exist total hip replacement contralateral side . Patient require simultaneous bilateral total hip replacement . Patient Body Mass Index ( BMI ) &gt; 45 . Patient active suspect latent infection affect hip joint time study device implantation . Patient neuromuscular neurosensory deficiency would create unacceptable risk instability , prosthesis fixation failure complication postoperative care , limit ability evaluate safety efficacy device . Patient bone stock inadequate support fixation prosthesis , diagnose systemic disease ( e.g . Lupus Erythematosus ) metabolic disorder ( e.g . Paget 's disease ) lead progressive bone deterioration . Patient immunologically suppress receive steroid excess normal physiological requirement ( e.g . &gt; 30 day ) . Patient known sensitivity device material . Patient prisoner .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>[ E04.555.110.110.110 ]</keyword>
</DOC>